Autism Spectrum Disorder Therapies Market Size, Share and Trend Analysis Report, By Therapeutic Type (Stimulants, Antipsychotics), By Application, By Distribution Channel, By Region and Segment Forecast, 2023-2030
NEW YORK, Jan. 06, 2023 (GLOBE NEWSWIRE) — Reportlinker.com publishes the report, “Autism Spectrum Disorder Therapeutics Market Size, Share & Trend Analysis Report, By Treatment Type, By Application, By Distribution Channel, By Region.” announced the release. Segment Forecast, 2023-2030” – https://www.reportlinker.com/p06377938/?utm_source=GNW
Autism Spectrum Disorder Treatment Market Growth and Trends
The global autism spectrum disorder treatment market size is expected to reach USD 3.28 billion by 2030, expanding at a CAGR of 6.1% from 2023 to 2030. We assess key theories about how genetic fingerprinting and the brain contribute to the development of autism. Pipeline medicines include Axial Therapeutics, Inc.’s AB-2004 & AB-2004 PTR, Zynerba Pharmaceuticals, Inc.’s Zygel and Impel Pharmaceuticals Inc.’s INP105 (olanzapine).
In July 2022, Impel Pharmaceuticals Inc. initiated the first patient dose in a Phase 2a trial evaluating INP-105 for the treatment of acute agitation in adolescents with autism spectrum disorder (ASD). The company uses Precision Olfactory Delivery (POD) technology to deliver drugs to the top of the nose without the need for an injection, enhancing drug absorption. Therefore, technological advancements in drug delivery are expected to drive the market.
In May 2020, HARMAN International and F. Hoffmann-La Roche Ltd. entered into a global partnership to develop a digital treatment platform for individuals with ASD. Under this partnership, Harman and Samsung have combined F. Hoffmann-La Roche Ltd.’s leadership in neuroscience and extensive technology to develop innovative therapies for the treatment of ASD.
Increased awareness and funding for Autism Spectrum Disorder R&D is expected to make a positive contribution to the market growth. Raise awareness among doctors and patients about the disease and the benefits of its treatment.
Additionally, in November 2022, the Defiance County Board of Developmental Disabilities/Good Samaritan School and the Andrew Jimenez Autism Foundation will receive donations from Buckeye roof and exterior owners to support awareness efforts about ASD. Received a donation of US$1,000. market growth.
Autism Spectrum Disorder Treatment Market Report Highlights
• By therapeutic type, the stimulant segment accounted for the largest share in 2022. This may be due to the market availability of FDA-approved stimulants for symptom management of the disease.
• Based on application, the autism segment will dominate the market in 2022 due to rising incidence of the disease. Three cohort studies found that the incidence of ASD is more than 3% of the population as of May 2021.
• In 2022, the hospital pharmacy segment will hold the second largest share. This growth can be attributed to an increase in inpatient visits for the diagnosis and treatment of sick patients.
• North America dominated the global market in 2022, owing to factors such as increased awareness among healthcare professionals regarding the treatment of autism spectrum disorders, availability of therapeutic drugs, and increased prevalence of the disease.
Read the full report: https://www.reportlinker.com/p06377938/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you can instantly get all the market research you need in one place.
CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001